Report Company Directory
- Osiris Therapeutics, Inc. Announces Closing of Acquisition by Smith & Nephew plc by GlobeNewsWire
- Osiris Therapeutics, Inc. Enters Agreement to be Acquired by Smith & Nephew plc by GlobeNewsWire
- Osiris Therapeutics, Inc. Appoints Samson Tom, PhD, MBA to Serve as President and Chief Executive Officer by GlobeNewsWire
- Osiris Therapeutics, Inc Reports Third Quarter 2018 Results by GlobeNewsWire
- Osiris Therapeutics, Inc. to Present Advanced Clinical and Scientific Abstracts at Symposium on Advanced Wound Care (SAWC) Fall Meeting, November 2-4, 2018, in Las Vegas, Nevada by GlobeNewsWire
- Osiris Therapeutics, Inc. Announces Peer-Reviewed Publication Demonstrating That Lyopreservation Method Developed for Living Tissues is an Alternative to Cryopreservation with the Convenience of Ambient Storage by GlobeNewsWire
- Osiris Therapeutics, Inc. Announces GrafixPL PRIMEâ„¢ Launches October 1, 2018 by GlobeNewsWire
- Osiris Therapeutics, Inc. Announces Peer-Reviewed Publication Comparing the Efficacy of Viable Cryopreserved Placental Membranes to Human Fibroblast-Derived Dermal Substitute in the Treatment of Chronic Diabetic Foot Ulcers (DFUs) in a Multicenter Randomi by GlobeNewsWire
- Osiris Therapeutics, Inc. to Re-list on The Nasdaq Global Market on August 1, 2018 by GlobeNewsWire
- Osiris Announces Enrollment of Patients in a Clinical Trial Evaluating GrafixPL PRIMEâ„¢ in the Treatment of Chronic Venous Leg Ulcers by GlobeNewsWire